Minghua Ge

9PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersHaematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 12, 2026
S1PR1-Overexpressing Membrane-Coated Nanoparticles Inhibit Dedifferentiation Progression for the Treatment of Anaplastic Thyroid Carcinoma by Targeting the ACER3/SPHK1/S1P Pathway.

|Feb 09, 2026
Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma.

Qiyue Wang, Zhuo Tan, Chuanming Zheng

|Jan 16, 2026
Clinical Significance for Risk Stratification of Papillary Thyroid Cancer by TUMORFISHER Circulating Tumor Cell Technique.

Liehao Jiang, Xuejie Li, Tianyi Ma

|Mar 17, 2025
Antigen-Targeting Inserted Nanomicelles Guide Pre-Existing Immunity to Kill Head and Neck Cancer.

Lizhuo Zhang, Qingqing Feng, Chuanming Zheng

|Jan 11, 2025
ERRATUM: Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer.

Jiajun Wu, Juyong Liang, Ruiqi Liu

|Mar 18, 2024
BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability.

Tiefeng Jin, Lingling Ding, Jinming Chen

Pageof 2

Frequent Collaborators

4 joint publications

Jiafeng Wang

3 joint publications

Jiajie Xu

3 joint publications

Juyong Liang

2 joint publications

Chuanming Zheng